Raymond James Financial Services Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.35M Buy
65,711
+4,752
+8% +$427K 0.01% 1108
2024
Q2
$5.23M Sell
60,959
-2,418
-4% -$203K 0.01% 1137
2024
Q1
$5.23M Sell
63,377
-17,753
-22% -$1.3M 0.01% 1111
2023
Q4
$5.41M Sell
81,130
-50,022
-38% -$3.24M 0.01% 1044
2023
Q3
$8.81M Sell
131,152
-14,190
-10% -$976K 0.02% 749
2023
Q2
$9.84M Sell
145,342
-8,046
-5% -$504K 0.02% 712
2023
Q1
$8.3M Buy
153,388
+29,911
+24% +$1.74M 0.02% 773
2022
Q4
$7.39M Sell
123,477
-2,539
-2% -$138K 0.01% 788
2022
Q3
$5.7M Sell
126,016
-61,148
-33% -$3.06M 0.01% 858
2022
Q2
$8.35M Sell
187,164
-14,123
-7% -$725K 0.02% 705
2022
Q1
$11.4M Buy
201,287
+29,361
+17% +$1.53M 0.02% 637
2021
Q4
$8.93M Buy
171,926
+123,339
+254% +$6.36M 0.02% 738
2021
Q3
$2.9M Buy
48,587
+5,549
+13% +$349K 0.01% 1266
2021
Q2
$2.67M Buy
43,038
+2,774
+7% +$185K 0.01% 1319
2021
Q1
$2.62M Sell
40,264
-1,587
-4% -$104K 0.01% 1244
2020
Q4
$2.75M Sell
41,851
-1,754
-4% -$103K 0.01% 1121
2020
Q3
$2.25M Buy
43,605
+28,873
+196% +$1.48M 0.01% 1107
2020
Q2
$726K Buy
14,732
+3,828
+35% +$207K ﹤0.01% 1690
2020
Q1
$556K Sell
10,904
-11,423
-51% -$659K ﹤0.01% 1485
2019
Q4
$1.23M Buy
22,327
+2,309
+12% +$125K ﹤0.01% 1435
2019
Q3
$1.01M Sell
20,018
-1,738
-8% -$87.3K ﹤0.01% 1473
2019
Q2
$1.1M Buy
21,756
+565
+3% +$27.4K ﹤0.01% 1450
2019
Q1
$985K Buy
21,191
+311
+1% +$15.8K ﹤0.01% 1461
2018
Q4
$1.02M Sell
20,880
-156
-0.7% -$8.87K 0.01% 1250
2018
Q3
$1.3M Buy
21,036
+12,677
+152% +$771K 0.01% 1311
2018
Q2
$450K Sell
8,359
-6,629
-44% -$331K ﹤0.01% 1947
2018
Q1
$682K Buy
+14,988
New +$643K ﹤0.01% 1540
2017
Q4
Sell
-9,972
Closed -$368K 2570
2017
Q3
$368K Buy
9,972
+306
+3% +$10.9K ﹤0.01% 1910
2017
Q2
$372K Buy
9,666
+1,157
+14% +$42.4K ﹤0.01% 1860
2017
Q1
$290K Buy
+8,509
New +$279K ﹤0.01% 1914
2013
Q3
Sell
-18,976
Closed -$435K 603
2013
Q2
$435K Buy
+18,976
New +$429K 0.01% 910

Other funds holding EHC

Raymond James Financial Services Advisors's EHC Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Encompass Health (EHC) stake by 7.8% in Q3 2024, buying an estimated $427K and bringing the position to 65,711 shares worth $6.35M. The position accounts for 0.01% of the portfolio, ranked #1108.

Raymond James Financial Services Advisors first reported a position in EHC in Q2 2013 and has held it in 31 quarters since. The position peaked at $11.4M in Q1 2022. 483 funds tracked by Wall St. Rank hold EHC as of Q3 2024.

  • Raymond James Financial Services Advisors held 65,711 shares of Encompass Health worth $6.35M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 4,752 Encompass Health shares in Q3 2024, an estimated $427K.
  • Encompass Health made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1108 holding.
  • Raymond James Financial Services Advisors first reported a position in Encompass Health in Q2 2013 and has held it in 31 quarters since.
  • Raymond James Financial Services Advisors's Encompass Health position peaked at $11.4M in Q1 2022.
  • 483 funds tracked by Wall St. Rank held Encompass Health as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.